StageZero Life Sciences Ltd's market cap is currently C$4.94M. The company's EPS TTM is C$-0.158; its P/E ratio is ―; StageZero Life Sciences Ltd is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 3.80M	$ 5.07M	$ 4.15M	$ 138.70K	$ 185.87K
Gross Profit	$ -403.75K	$ 1.18M	$ 695.55K	$ -960.91K	$ -1.08M
Operating Income	$ -7.75M	$ -8.13M	$ -3.70M	$ -5.11M	$ -4.36M
EBITDA	$ -10.76M	$ -7.62M	$ -3.48M	$ -4.81M	$ -4.04M
Net Income	$ -11.42M	$ -7.68M	$ -7.18M	$ -4.31M	$ -3.94M
Balance Sheet
Cash & Short-Term Investments	$ 15.68K	$ 1.72M	$ 6.60M	$ 71.12K	$ 106.23K
Total Assets	$ 700.65K	$ 10.65M	$ 8.51M	$ 1.96M	$ 2.49M
Total Debt	$ 1.80M	$ 1.36M	$ 3.57M	$ 2.46M	$ 3.22M
Net Debt	$ 1.78M	$ -368.50K	$ -3.03M	$ 2.39M	$ 3.12M
Total Liabilities	$ 8.20M	$ 7.88M	$ 9.74M	$ 6.46M	$ 7.32M
Stockholders' Equity	$ -7.50M	$ 2.76M	$ -1.23M	$ -4.49M	$ -4.84M
Cash Flow
Free Cash Flow	$ -3.53M	$ -9.10M	$ -3.14M	$ -4.64M	$ -3.29M
Operating Cash Flow	$ -3.53M	$ -8.95M	$ -3.06M	$ -4.59M	$ -3.29M
Investing Cash Flow	$ 0.00	$ -20.96K	$ -72.32K	$ -33.38K	$ -2.79K
Financing Cash Flow	$ 1.83M	$ 4.10M	$ 9.66M	$ 4.59M	$ 3.36M

Currency in USD

StageZero Life Sciences Ltd Earnings and Revenue History

Income Statement >

StageZero Life Sciences Ltd Debt to Assets

Balance Sheet >

StageZero Life Sciences Ltd Cash Flow

Cash Flow >

StageZero Life Sciences Ltd Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing